Today's Economist has an article about Advance Market Commitments which describes criticisms of the idea by Oxford economist, Andrew Farlow. (The full text of the Economist article is below).
The article mentions three of Dr Farlow's concerns:
- that the terms might create an incentive for less effective vaccines
- that drugs companies might use bribes to increase their share of the valuable market
- that the promise of future purchases might not be credible